Sevil Ceyhan Doğan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sevil Ceyhan Doğan has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Mert Atas
Sivas Cumhuriyet Üniversitesi
6 shared publications - Ayca Tas
Sivas Cumhuriyet Üniversitesi
4 shared publications - Ahmet Karadağ
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Türkiye
2 shared publications - Cemile Zontul
Sivas Cumhuriyet Üniversitesi
2 shared publications - Gonca Kabak
Sivas Cumhuriyet Üniversitesi
2 shared publications - Gulcihan Cinar Kaya
Department of Medical Services and Techniques, Yıldızeli Vocational School, Medical Laboratory Techniques Program, Sivas Cumhuriyet University, 58140 Sivas, Türkiye
2 shared publications
Latest Publications
- 31 August 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (4) , 690-700
Gene Expression Analysis of Inflammation, Apoptosis, and DNA Repair Mechanisms in the Pathogenesis of Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease characterized by persistent inflammation, oxidative stress, immune dysregulation, and abnormal bone remodeling. Recent evidence suggests that microRNA-mediated post-transcriptional regulation and DNA damage response pathways may contribute to AS pathogenesis. This study aimed to investigate the expression profiles of selected microRNAs and genes associated with inflammation, apoptosis, and DNA repair mechanisms in patients with AS. A total of 30 patients diagnosed with AS and 30 healthy controls were included in the study. Gene and microRNA expression levels, including miRNA-574-5p, miRNA-30c-5p, MDM2, RAD51, NFKB1, BAX, ERCC1, and ATR, were analyzed using quantitative real-time PCR (qRT-PCR). Inflammatory parameters, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and interleukin-6 (IL-6), were also evaluated. The results demonstrated significantly increased miRNA-574-5p expression and significantly decreased MDM2 expression in the AS group compared with controls (p<0.05). CRP and IL-6 levels were also significantly elevated in patients with AS. Logistic regression analysis identified miRNA-574-5p, MDM2, and CRP as independently associated with AS. Receiver operating characteristic (ROC) analysis revealed that miRNA-574-5p and MDM2 exhibited significant diagnostic performance for distinguishing AS patients from healthy individuals. Correlation analyses demonstrated a positive association between miRNA-574-5p and BAX, whereas a negative correlation was observed between miRNA-574-5p and ESR. These findings suggest that altered miRNA-574-5p and MDM2 expression may contribute to inflammatory activity, apoptosis, and cellular stress responses in AS. Overall, the findings suggest that altered miRNA-574-5p and MDM2 expression may be associated with ankylosing spondylitis and represent candidate molecular biomarkers that warrant further validation in larger independent cohorts.
- 31 August 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (4) , 690-700
Gene Expression Analysis of Inflammation, Apoptosis, and DNA Repair Mechanisms in the Pathogenesis of Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease characterized by persistent inflammation, oxidative stress, immune dysregulation, and abnormal bone remodeling. Recent evidence suggests that microRNA-mediated post-transcriptional regulation and DNA damage response pathways may contribute to AS pathogenesis. This study aimed to investigate the expression profiles of selected microRNAs and genes associated with inflammation, apoptosis, and DNA repair mechanisms in patients with AS. A total of 30 patients diagnosed with AS and 30 healthy controls were included in the study. Gene and microRNA expression levels, including miRNA-574-5p, miRNA-30c-5p, MDM2, RAD51, NFKB1, BAX, ERCC1, and ATR, were analyzed using quantitative real-time PCR (qRT-PCR). Inflammatory parameters, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and interleukin-6 (IL-6), were also evaluated. The results demonstrated significantly increased miRNA-574-5p expression and significantly decreased MDM2 expression in the AS group compared with controls (p<0.05). CRP and IL-6 levels were also significantly elevated in patients with AS. Logistic regression analysis identified miRNA-574-5p, MDM2, and CRP as independently associated with AS. Receiver operating characteristic (ROC) analysis revealed that miRNA-574-5p and MDM2 exhibited significant diagnostic performance for distinguishing AS patients from healthy individuals. Correlation analyses demonstrated a positive association between miRNA-574-5p and BAX, whereas a negative correlation was observed between miRNA-574-5p and ESR. These findings suggest that altered miRNA-574-5p and MDM2 expression may contribute to inflammatory activity, apoptosis, and cellular stress responses in AS. Overall, the findings suggest that altered miRNA-574-5p and MDM2 expression may be associated with ankylosing spondylitis and represent candidate molecular biomarkers that warrant further validation in larger independent cohorts.
- Open Access
- 14 August 2026
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 32 (4) , 496-505
Association Between Vitamin D Levels and Fatigue in Patients with Spinal Cord Injury
Objective: Fatigue frequently occurs after spinal cord injury (SCI) and can markedly diminish quality of life. Studies involving different patient groups have reported links between deficient vitamin D status, fatigue, and compromised neuromuscular performance. Accordingly, we evaluated the association of circulating 25-hydroxyvitamin D [25(OH) D] with fatigue among individuals with SCI. Methods: A single-center, cross-sectional design was used to compare 25 individuals with SCI with 25 healthy participants matched for age and sex. Serum 25(OH) D was assayed to characterize vitamin D status. The Chalder Fatigue Scale (CFS) was used to quantify fatigue, whereas the Functional Independence Measure (FIM) provided the measure of functional independence. Correlations of serum 25(OH) D with CFS scores were calculated within the SCI cohort. Results: Compared with controls, participants with SCI showed reduced serum 25(OH) D concentrations (19.82 ± 10.69 vs. 29.20 ± 14.83 ng/mL, p = 0.014) and elevated physical, mental, and total fatigue scores (all p < 0.001). In the SCI group, serum vitamin D was inversely related to total fatigue (rs = −0.899, p < 0.001) and physical fatigue (rs=−0.955, p < 0.001); the inverse relation with mental fatigue was moderate (rs = −0.479, p = 0.015). Its association with the FIM motor score was not statistically significant. After adjustment for time since injury, AIS grade, and injury level, the inverse associations with physical and total fatigue persisted (partial rs = −0.945 and −0.882, respectively; both p < 0.001). Conclusion: Low vitamin D status was frequent among individuals with SCI and was accompanied by greater fatigue, most notably in the physical domain. Serum vitamin D was inversely associated with fatigue in this population; however, the cross-sectional design precludes causal inference, and shared determinants such as immobility and reduced sun exposure may partly explain this relationship. Larger prospective and interventional studies are required to define this relationship more clearly.
- 14 August 2026
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 32 (4) , 496-505
Open AccessAssociation Between Vitamin D Levels and Fatigue in Patients with Spinal Cord Injury
Objective: Fatigue frequently occurs after spinal cord injury (SCI) and can markedly diminish quality of life. Studies involving different patient groups have reported links between deficient vitamin D status, fatigue, and compromised neuromuscular performance. Accordingly, we evaluated the association of circulating 25-hydroxyvitamin D [25(OH) D] with fatigue among individuals with SCI. Methods: A single-center, cross-sectional design was used to compare 25 individuals with SCI with 25 healthy participants matched for age and sex. Serum 25(OH) D was assayed to characterize vitamin D status. The Chalder Fatigue Scale (CFS) was used to quantify fatigue, whereas the Functional Independence Measure (FIM) provided the measure of functional independence. Correlations of serum 25(OH) D with CFS scores were calculated within the SCI cohort. Results: Compared with controls, participants with SCI showed reduced serum 25(OH) D concentrations (19.82 ± 10.69 vs. 29.20 ± 14.83 ng/mL, p = 0.014) and elevated physical, mental, and total fatigue scores (all p < 0.001). In the SCI group, serum vitamin D was inversely related to total fatigue (rs = −0.899, p < 0.001) and physical fatigue (rs=−0.955, p < 0.001); the inverse relation with mental fatigue was moderate (rs = −0.479, p = 0.015). Its association with the FIM motor score was not statistically significant. After adjustment for time since injury, AIS grade, and injury level, the inverse associations with physical and total fatigue persisted (partial rs = −0.945 and −0.882, respectively; both p < 0.001). Conclusion: Low vitamin D status was frequent among individuals with SCI and was accompanied by greater fatigue, most notably in the physical domain. Serum vitamin D was inversely associated with fatigue in this population; however, the cross-sectional design precludes causal inference, and shared determinants such as immobility and reduced sun exposure may partly explain this relationship. Larger prospective and interventional studies are required to define this relationship more clearly.
- Open Access
- 27 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5823
Immune Regulatory Endotypes Defined by TRIM-Dependent Ubiquitin Signaling and IFN–NF-κB Network Activity in Ankylosing Spondylitis
Ankylosing Spondylitis (AS) is a chronic inflammatory autoimmune rheumatic disease that primarily affects the spine and sacroiliac joints. This study aimed to investigate the expression levels of immune response-related genes, including IRF7, NFKB1A, TNFAIP3, STAT1, TRIM21, TRIM22, and TRIM25, as well as the serum levels of CXCL10 and SIRPA proteins in patients with AS. In addition, the potential diagnostic performance of these molecular and serum biomarkers in distinguishing patients with AS from healthy controls was evaluated. A total of 45 patients with AS and 44 healthy controls were included in the study. Immune-related gene expression levels were analyzed using RT-PCR. In addition, serum CXCL10 and SIRPA protein levels were evaluated using ELISA. The expression levels of NFKB1A, TNFAIP3, IRF7, STAT1, and TRIM21 were significantly increased in patients with AS compared to healthy controls (p < 0.05). In contrast, no significant differences were detected in the expression levels of TRIM22 and TRIM25. In the ROC analysis, the highest diagnostic performance was obtained for NFKB1A (AUC = 0.741), TNFAIP3 (AUC = 0.720), and TRIM21 (AUC = 0.722). Serum CXCL10 and SIRPA levels were not significantly different between the groups. In AS, genes particularly associated with NF-κB and interferon signaling pathways (NFKB1A, TNFAIP3, IRF7, STAT1, and TRIM21) were found to be significantly altered, and these genes may serve as potential molecular biomarkers for AS. In contrast, the diagnostic power of serum protein biomarkers is limited. These findings indicate that the potential of these genes as biomarkers for AS pathogenesis should be further supported by advanced studies evaluating their expression levels.
- 27 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5823
Open AccessImmune Regulatory Endotypes Defined by TRIM-Dependent Ubiquitin Signaling and IFN–NF-κB Network Activity in Ankylosing Spondylitis
Ankylosing Spondylitis (AS) is a chronic inflammatory autoimmune rheumatic disease that primarily affects the spine and sacroiliac joints. This study aimed to investigate the expression levels of immune response-related genes, including IRF7, NFKB1A, TNFAIP3, STAT1, TRIM21, TRIM22, and TRIM25, as well as the serum levels of CXCL10 and SIRPA proteins in patients with AS. In addition, the potential diagnostic performance of these molecular and serum biomarkers in distinguishing patients with AS from healthy controls was evaluated. A total of 45 patients with AS and 44 healthy controls were included in the study. Immune-related gene expression levels were analyzed using RT-PCR. In addition, serum CXCL10 and SIRPA protein levels were evaluated using ELISA. The expression levels of NFKB1A, TNFAIP3, IRF7, STAT1, and TRIM21 were significantly increased in patients with AS compared to healthy controls (p < 0.05). In contrast, no significant differences were detected in the expression levels of TRIM22 and TRIM25. In the ROC analysis, the highest diagnostic performance was obtained for NFKB1A (AUC = 0.741), TNFAIP3 (AUC = 0.720), and TRIM21 (AUC = 0.722). Serum CXCL10 and SIRPA levels were not significantly different between the groups. In AS, genes particularly associated with NF-κB and interferon signaling pathways (NFKB1A, TNFAIP3, IRF7, STAT1, and TRIM21) were found to be significantly altered, and these genes may serve as potential molecular biomarkers for AS. In contrast, the diagnostic power of serum protein biomarkers is limited. These findings indicate that the potential of these genes as biomarkers for AS pathogenesis should be further supported by advanced studies evaluating their expression levels.
- Open Access
Receptor–Ligand Biomarker Profile in Ankylosing Spondylitis: Associations Between AXL/MERTK Expression, Circulating GAS6 and Protein S Levels, and Disease Activity
(1) Background: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with immune dysregulation. The TYRO3, AXL, and MER (TAM) signaling pathway, comprising AXL receptor tyrosine kinase (AXL), MER tyrosine kinase (MERTK), growth arrest-specific 6 (GAS6), and Protein S, is a key regulator of immune homeostasis. This study investigated these receptor–ligand components in patients with AS. (2) Methods: A total of 45 patients with AS and 44 healthy controls were enrolled. Serum GAS6 and Protein S levels were measured by ELISA, and AXL and MERTK expression levels were analyzed by RT-qPCR. Clinical and inflammatory parameters were also evaluated. (3) Results: ESR, CRP, and IL-6 levels were significantly higher, whereas Protein S levels were significantly lower in patients with AS than in controls. No significant differences were observed in GAS6, AXL, or MERTK expression levels, although lower expression trends were detected in patients. Logistic regression analysis identified CRP, IL-6, Protein S, and AXL expression as variables independently associated with AS. ROC analysis demonstrated significant discriminatory performance for AXL expression. (4) Conclusions: Alterations in the TAM signaling pathway, particularly reduced Protein S levels and altered AXL expression, may contribute to immune dysregulation and persistent inflammation in AS.
Open AccessReceptor–Ligand Biomarker Profile in Ankylosing Spondylitis: Associations Between AXL/MERTK Expression, Circulating GAS6 and Protein S Levels, and Disease Activity
(1) Background: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with immune dysregulation. The TYRO3, AXL, and MER (TAM) signaling pathway, comprising AXL receptor tyrosine kinase (AXL), MER tyrosine kinase (MERTK), growth arrest-specific 6 (GAS6), and Protein S, is a key regulator of immune homeostasis. This study investigated these receptor–ligand components in patients with AS. (2) Methods: A total of 45 patients with AS and 44 healthy controls were enrolled. Serum GAS6 and Protein S levels were measured by ELISA, and AXL and MERTK expression levels were analyzed by RT-qPCR. Clinical and inflammatory parameters were also evaluated. (3) Results: ESR, CRP, and IL-6 levels were significantly higher, whereas Protein S levels were significantly lower in patients with AS than in controls. No significant differences were observed in GAS6, AXL, or MERTK expression levels, although lower expression trends were detected in patients. Logistic regression analysis identified CRP, IL-6, Protein S, and AXL expression as variables independently associated with AS. ROC analysis demonstrated significant discriminatory performance for AXL expression. (4) Conclusions: Alterations in the TAM signaling pathway, particularly reduced Protein S levels and altered AXL expression, may contribute to immune dysregulation and persistent inflammation in AS.
- Open Access
The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis
This study evaluated the structural, electronic, pharmacokinetic, and receptor-binding properties of three bisphosphonate derivatives, alendronate, risedronate, and zoledronate, to investigate their therapeutic relevance in osteoporosis and breast cancer. Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d,p) level showed that risedronate exhibited the highest kinetic stability (ΔE = 6.7468 eV), whereas zoledronate displayed greater chemical reactivity (ΔE = 2.9669 eV) and the strongest nonlinear optical response (β = 1.20 × 10−30 esu). ADMET analysis indicated acceptable safety profiles for all compounds, although high polarity and low lipophilicity may limit oral bioavailability. Molecular docking against 11 breast cancer- and bone metabolism-related targets revealed favorable binding affinities, particularly for zoledronate and risedronate. Zoledronate showed strong interactions with ESR2, VEGFR/KDR, GGPS1, and FPPS, whereas risedronate exhibited notable affinity for BRCA2 and MMP9. Bioinformatics analyses identified significant dysregulation of GGPS1, FDPS, TNFSF11, ESR1, MMP9, and BRCA2 in breast cancer tissues, while survival analysis linked elevated FDPS, MMP9, and BRCA2 expression to poor prognosis. Network analyses highlighted pathways related to mevalonate metabolism, hormone signaling, angiogenesis, extracellular matrix remodeling, and the RANK/RANKL/OPG axis. These findings support the potential repurposing of bisphosphonates, particularly zoledronate, for breast cancer-associated bone disease.
Open AccessThe Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis
This study evaluated the structural, electronic, pharmacokinetic, and receptor-binding properties of three bisphosphonate derivatives, alendronate, risedronate, and zoledronate, to investigate their therapeutic relevance in osteoporosis and breast cancer. Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d,p) level showed that risedronate exhibited the highest kinetic stability (ΔE = 6.7468 eV), whereas zoledronate displayed greater chemical reactivity (ΔE = 2.9669 eV) and the strongest nonlinear optical response (β = 1.20 × 10−30 esu). ADMET analysis indicated acceptable safety profiles for all compounds, although high polarity and low lipophilicity may limit oral bioavailability. Molecular docking against 11 breast cancer- and bone metabolism-related targets revealed favorable binding affinities, particularly for zoledronate and risedronate. Zoledronate showed strong interactions with ESR2, VEGFR/KDR, GGPS1, and FPPS, whereas risedronate exhibited notable affinity for BRCA2 and MMP9. Bioinformatics analyses identified significant dysregulation of GGPS1, FDPS, TNFSF11, ESR1, MMP9, and BRCA2 in breast cancer tissues, while survival analysis linked elevated FDPS, MMP9, and BRCA2 expression to poor prognosis. Network analyses highlighted pathways related to mevalonate metabolism, hormone signaling, angiogenesis, extracellular matrix remodeling, and the RANK/RANKL/OPG axis. These findings support the potential repurposing of bisphosphonates, particularly zoledronate, for breast cancer-associated bone disease.
- Open Access
- 31 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3164
Serum Levels of Glutamatergic (GRIN1) and Purinergic (P2RX1/P2RY2) Receptors in Patients with Fibromyalgia
Fibromyalgia (FM) is a chronic pain syndrome characterized by central sensitization, in which glutamatergic and purinergic signaling pathways are thought to play critical roles. This study aimed to evaluate the diagnostic potential of serum glutamate ionotropic receptor N-methyl-D-aspartate type subunit 1 (GRIN1), purinergic receptor P2X 1 (P2RX1), and purinergic receptor P2Y 2 (P2RY2) levels in patients with FM. A total of 93 newly diagnosed FM patients and 93 age- and sex-matched healthy controls were included in the study. Serum levels of GRIN1, P2RX1, and P2RY2 were measured using enzyme-linked immunosorbent assay (ELISA). Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic performance of these biomarkers. ROC analysis demonstrated good diagnostic accuracy for all three biomarkers. The area under the curve (AUC) values were 0.817 for GRIN1, 0.778 for P2RX1, and 0.842 for P2RY2 (p < 0.001 for all). At optimal cut-off values, GRIN1, P2RX1, and P2RY2 showed sensitivities of 91.4%, 78.5%, and 92.5%, and specificities of 72.00%, 75.3%, and 80.6%, respectively. Serum GRIN1, P2RX1, and P2RY2 levels exhibit strong diagnostic performance in FM and may serve as promising biomarkers reflecting altered glutamatergic and purinergic signaling in disease pathophysiology.
- 31 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3164
Open AccessSerum Levels of Glutamatergic (GRIN1) and Purinergic (P2RX1/P2RY2) Receptors in Patients with Fibromyalgia
Fibromyalgia (FM) is a chronic pain syndrome characterized by central sensitization, in which glutamatergic and purinergic signaling pathways are thought to play critical roles. This study aimed to evaluate the diagnostic potential of serum glutamate ionotropic receptor N-methyl-D-aspartate type subunit 1 (GRIN1), purinergic receptor P2X 1 (P2RX1), and purinergic receptor P2Y 2 (P2RY2) levels in patients with FM. A total of 93 newly diagnosed FM patients and 93 age- and sex-matched healthy controls were included in the study. Serum levels of GRIN1, P2RX1, and P2RY2 were measured using enzyme-linked immunosorbent assay (ELISA). Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic performance of these biomarkers. ROC analysis demonstrated good diagnostic accuracy for all three biomarkers. The area under the curve (AUC) values were 0.817 for GRIN1, 0.778 for P2RX1, and 0.842 for P2RY2 (p < 0.001 for all). At optimal cut-off values, GRIN1, P2RX1, and P2RY2 showed sensitivities of 91.4%, 78.5%, and 92.5%, and specificities of 72.00%, 75.3%, and 80.6%, respectively. Serum GRIN1, P2RX1, and P2RY2 levels exhibit strong diagnostic performance in FM and may serve as promising biomarkers reflecting altered glutamatergic and purinergic signaling in disease pathophysiology.
- 26 August 2025
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 21 (3) , 1-11
Bibliometric Analysis of Capillaroscopy Use in Systemic Sclerosis: Current State and Advances from 2000 to 2024
Introduction: Systemic sclerosis is a complex autoimmune disease characterized by diverse clinical manifestations that vary among individuals. It is associated with significant morbidity and mortality. This study aimed to evaluate the existing literature on the use of capillaroscopy in systemic sclerosis and to perform a bibliometric analysis. Methods: Data were downloaded from Scopus on 2nd October 2024, and analyzed using VOSviewer and the Biblioshiny package programs. Results: A total of 819 articles from 246 sources were analyzed. Italy led in the number of publications (n=209) and the frequency of international cooperation. The article, titled "Nailfold Videocapillaroscopy Assessment of Microvascular Damage in Systemic Sclerosis," published in The Journal of Rheumatology, has garnered 606 citations, making it the most cited article. Cutolo M. was the most influential author, with 1302 citations and 107 publications, while the University of Genova was the most prolific institution. The investigation identified significant issue clusters in the literature related to keywords, such as "systemic sclerosis," "Raynaud';s phenomenon," "capillaroscopy," and "digital ulcers." Discussion: This study presents the first comprehensive bibliometric analysis of capillaroscopy use in systemic sclerosis. The findings suggest that scientific interest in the subject is increasing and that research leadership is primarily located in European countries, with Italy at the forefront. The most frequently used keywords in the thematic analysis indicated that capillaroscopy can be used not only for diagnosis but also for monitoring complications. The use of only the Scopus database and the inclusion of only original articles in the study constitute limitations. This methodological choice was made to ensure data integrity. Conclusion: Understanding the research on capillaroscopy applications in systemic sclerosis can benefit rheumatologists and provide ideas for future investigations. This bibliometric analysis highlights key authors, citation patterns, collaboration structures, and emerging research issues over the past two decades, providing a comprehensive overview of the discipline.
- 26 August 2025
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 21 (3) , 1-11
Bibliometric Analysis of Capillaroscopy Use in Systemic Sclerosis: Current State and Advances from 2000 to 2024
Introduction: Systemic sclerosis is a complex autoimmune disease characterized by diverse clinical manifestations that vary among individuals. It is associated with significant morbidity and mortality. This study aimed to evaluate the existing literature on the use of capillaroscopy in systemic sclerosis and to perform a bibliometric analysis. Methods: Data were downloaded from Scopus on 2nd October 2024, and analyzed using VOSviewer and the Biblioshiny package programs. Results: A total of 819 articles from 246 sources were analyzed. Italy led in the number of publications (n=209) and the frequency of international cooperation. The article, titled "Nailfold Videocapillaroscopy Assessment of Microvascular Damage in Systemic Sclerosis," published in The Journal of Rheumatology, has garnered 606 citations, making it the most cited article. Cutolo M. was the most influential author, with 1302 citations and 107 publications, while the University of Genova was the most prolific institution. The investigation identified significant issue clusters in the literature related to keywords, such as "systemic sclerosis," "Raynaud';s phenomenon," "capillaroscopy," and "digital ulcers." Discussion: This study presents the first comprehensive bibliometric analysis of capillaroscopy use in systemic sclerosis. The findings suggest that scientific interest in the subject is increasing and that research leadership is primarily located in European countries, with Italy at the forefront. The most frequently used keywords in the thematic analysis indicated that capillaroscopy can be used not only for diagnosis but also for monitoring complications. The use of only the Scopus database and the inclusion of only original articles in the study constitute limitations. This methodological choice was made to ensure data integrity. Conclusion: Understanding the research on capillaroscopy applications in systemic sclerosis can benefit rheumatologists and provide ideas for future investigations. This bibliometric analysis highlights key authors, citation patterns, collaboration structures, and emerging research issues over the past two decades, providing a comprehensive overview of the discipline.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (4) , 1139-1147
The clinical and demographical characteristics of Turkish pediatric lymphedema patients: a multicenter study
Background/aim: Reducing lymphedema-associated burden and disability in the pediatric setting requires improved awareness and understanding clinical properties of the lymphedema. The aim of this study was to evaluate the clinical and demographic characteristics of patients with pediatric lymphedema presented to different lymphedema centers in Turkey. Materials and methods: The socio-demographic and clinical characteristics of the children including age, gender, presence of genetic syndromes, duration of edema, site and stage of lymphedema and the received therapies were determined. Parental and children education on self-management techniques were recorded. Results: A total of 122 children (female: 66, male: 56) with a mean age of 120.7 ± 71.2 months were included from 7 centers. Of them; 92% had primary, 8% had secondary lymphedema mostly due to infection and trauma. Lymphedema was part of a syndrome in 18% of the children. The most common site of involvement was the lower extremity, followed by upper extremity and genital involvement. Lymphedema was complicated in 17 % of children, mainly with a clinical picture of cellulitis, infection, and pain. The median duration of lymphedema was 41 (5-216) months. Although most of the children had stage 2 lymphedema, only 40% of them received treatment. The most commonly received treatment was compression therapy. No family or child was educated for self- care management before. Conclusion: In conclusion, pediatric lymphedema has a comparable gender distribution and usually involves the lower extremities. Although most of the children had advanced disease, more than half of the patients did not receive any treatment indicating the unmet need for management of lymphedema. The education of patients and/or children about self-management methods were lacking. We suggest educational activities for both families of children with lymphedema and health care providers, in order to facilitate early reference to lymphedema units and to receive prompt preventive and therapeutic approaches for this suffering condition.
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (4) , 1139-1147
Open AccessThe clinical and demographical characteristics of Turkish pediatric lymphedema patients: a multicenter study
Background/aim: Reducing lymphedema-associated burden and disability in the pediatric setting requires improved awareness and understanding clinical properties of the lymphedema. The aim of this study was to evaluate the clinical and demographic characteristics of patients with pediatric lymphedema presented to different lymphedema centers in Turkey. Materials and methods: The socio-demographic and clinical characteristics of the children including age, gender, presence of genetic syndromes, duration of edema, site and stage of lymphedema and the received therapies were determined. Parental and children education on self-management techniques were recorded. Results: A total of 122 children (female: 66, male: 56) with a mean age of 120.7 ± 71.2 months were included from 7 centers. Of them; 92% had primary, 8% had secondary lymphedema mostly due to infection and trauma. Lymphedema was part of a syndrome in 18% of the children. The most common site of involvement was the lower extremity, followed by upper extremity and genital involvement. Lymphedema was complicated in 17 % of children, mainly with a clinical picture of cellulitis, infection, and pain. The median duration of lymphedema was 41 (5-216) months. Although most of the children had stage 2 lymphedema, only 40% of them received treatment. The most commonly received treatment was compression therapy. No family or child was educated for self- care management before. Conclusion: In conclusion, pediatric lymphedema has a comparable gender distribution and usually involves the lower extremities. Although most of the children had advanced disease, more than half of the patients did not receive any treatment indicating the unmet need for management of lymphedema. The education of patients and/or children about self-management methods were lacking. We suggest educational activities for both families of children with lymphedema and health care providers, in order to facilitate early reference to lymphedema units and to receive prompt preventive and therapeutic approaches for this suffering condition.
- 5 January 2021
- Published by Kocaeli Universitesi Saglik Bilimleri Dergisi in Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 7 (1) , 65-69
Hemodiyaliz Hastalarında Fibromiyalji Sendromu Prevalansı ve Yaşam Kalitesine Etkisi
Objective: We evaluated the prevalence of fibromyalgia syndrome (FM) in hemodialysis patients and whether this syndrome was associated with gender, age, duration of hemodialysis, or other laboratory parameters. Methods: The study included 248 patients with chronic kidney disease (CKD) undergoing hemodialysis. The patients were stratified into two groups: patients with FM based on the 2010 American College of Rheumatology diagnostic criteria and patients not meeting these criteria without FM. Quality of life (QOL) was assessed using the Short Form-36 (SF-36) and Kidney Disease Quality of Life-36 (KDQOL-36) questionnaires. Sociodemographic data, laboratory parameters and a marker for adequacy of hemodialysis (Kt/V) were recorded. Results: FM was detected in 33/248 (13.3%) of patients included. All patients diagnosed as FM were female. When all sub-parameters of SF-36 and KDQOL-36 were compared, QOL was lower in the FM group compared to patients without FM (p0.05). FM frequency was higher in cases of advanced age, presence of systemic disease and/or hepatitis B and C infection in patients undergoing hemodialysis (p<0.05). In addition, FM frequency was inversely proportional to education level (p<0.05). Conclusion: FM, associated with a significant decrease in QOL, is more commonly seen in CKD patients undergoing dialysis compared to the general population. Thus, it will be helpful to keep FM in mind and to improve QOL in these patients by early diagnosis and treatment.
- 5 January 2021
- Published by Kocaeli Universitesi Saglik Bilimleri Dergisi in Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 7 (1) , 65-69
Hemodiyaliz Hastalarında Fibromiyalji Sendromu Prevalansı ve Yaşam Kalitesine Etkisi
Objective: We evaluated the prevalence of fibromyalgia syndrome (FM) in hemodialysis patients and whether this syndrome was associated with gender, age, duration of hemodialysis, or other laboratory parameters. Methods: The study included 248 patients with chronic kidney disease (CKD) undergoing hemodialysis. The patients were stratified into two groups: patients with FM based on the 2010 American College of Rheumatology diagnostic criteria and patients not meeting these criteria without FM. Quality of life (QOL) was assessed using the Short Form-36 (SF-36) and Kidney Disease Quality of Life-36 (KDQOL-36) questionnaires. Sociodemographic data, laboratory parameters and a marker for adequacy of hemodialysis (Kt/V) were recorded. Results: FM was detected in 33/248 (13.3%) of patients included. All patients diagnosed as FM were female. When all sub-parameters of SF-36 and KDQOL-36 were compared, QOL was lower in the FM group compared to patients without FM (p0.05). FM frequency was higher in cases of advanced age, presence of systemic disease and/or hepatitis B and C infection in patients undergoing hemodialysis (p<0.05). In addition, FM frequency was inversely proportional to education level (p<0.05). Conclusion: FM, associated with a significant decrease in QOL, is more commonly seen in CKD patients undergoing dialysis compared to the general population. Thus, it will be helpful to keep FM in mind and to improve QOL in these patients by early diagnosis and treatment.
- Open Access
- 31 December 2020
- Published by Ege Tip Bilimleri Dergisi in Ege Tıp Bilimleri Dergisi
- Vol. 3 (3) , 111-116
Ratlarda Deneysel Artrit Modelinde Stronsiyum Kloridin Anti-İnlamatuvar Etkinliğinin Araştırılması
AMAÇ: Stronsiyum (Sr), osteoporoz tedavisinde uzun yıllardır kullanılan bir ilaçtır. Son dönemlerde Sr’nin pro-inflamatuvar sitokinleri inhibe ederek anti-inflamatuvar etkiler yaptığı gösterilmiştir. Bu çalışmanın amacı, Sr kloridin anti-inflamatuvar etkilerini ratlarda Freund’s Complete Adjuvan (FCA) kullanılarak oluşturulan deneysel artrit modelinde klinik, histopatolojik, immunohistokimyasal TNF-α ve TNF-α, IL-1 β, IL-6 serum seviyeleri ile değerlendirmektir. YÖNTEM: Çalışmaya 48 adet wistar-albino cinsi dişi rat alınmıştır. Ratlar randomize olarak her grupta 8 rat olacak biçimde toplam 6 gruba ayrıldı. Grup I kontrol grubudur, diğer gruplarda deneysel artrit modeli oluşturulmuştur. Grup II artrit kontrol olarak ayrılmıştır. Grup III, Grup IV ve Grup V’e Sr klorid oral olarak verilmiştir. Grup VI’ya diklofenak sodyum oral olarak verilmiştir. Deney sürecinde aralıklı olarak grupların ağırlık ölçümleri, sağ pençe çevresi ölçümleri ve klinik artrit skorları takip edilmiştir. Deney sonunda deneklerden alınan kan örneklerinden serum TNF-α, IL-1 β, IL-6 çalışılmıştır. Alınan doku örneklerinden histopatolojik olarak inflamasyon skoru, sinovyal hiperplazi, kıkırdak erozyonu ve kemik erozyonu değerlendirilmiştir. Alınan doku örneklerinden immunohistokimyasal TNF-α değerlendirilmiştir. BULGULAR: Sr kloridin anti-inflamatuvar etkileri değerlendirmelerde gösterilmiştir. Serum örneklerinden çalışılan TNF-α, IL-1 β, IL-6 seviyelerinde gruplar arasında anlamlı farklılık yoktu. İmmunohistokimyasal TNF-α değerlendirmesinde kontrol grubu hariç diğer gruplarda anlamlı farklılık yoktu. SONUÇ: Çalışmamızda Sr kloridin anti-inflamatuvar etkileri klinik ve histopatolojik değerlendirmeler ile gösterilmiştir. Bu sonuçlar Romatoid Artrit tedavisinde Sr kloridin kullanılabileceğini düşündürmektedir.
- 31 December 2020
- Published by Ege Tip Bilimleri Dergisi in Ege Tıp Bilimleri Dergisi
- Vol. 3 (3) , 111-116
Open AccessRatlarda Deneysel Artrit Modelinde Stronsiyum Kloridin Anti-İnlamatuvar Etkinliğinin Araştırılması
AMAÇ: Stronsiyum (Sr), osteoporoz tedavisinde uzun yıllardır kullanılan bir ilaçtır. Son dönemlerde Sr’nin pro-inflamatuvar sitokinleri inhibe ederek anti-inflamatuvar etkiler yaptığı gösterilmiştir. Bu çalışmanın amacı, Sr kloridin anti-inflamatuvar etkilerini ratlarda Freund’s Complete Adjuvan (FCA) kullanılarak oluşturulan deneysel artrit modelinde klinik, histopatolojik, immunohistokimyasal TNF-α ve TNF-α, IL-1 β, IL-6 serum seviyeleri ile değerlendirmektir. YÖNTEM: Çalışmaya 48 adet wistar-albino cinsi dişi rat alınmıştır. Ratlar randomize olarak her grupta 8 rat olacak biçimde toplam 6 gruba ayrıldı. Grup I kontrol grubudur, diğer gruplarda deneysel artrit modeli oluşturulmuştur. Grup II artrit kontrol olarak ayrılmıştır. Grup III, Grup IV ve Grup V’e Sr klorid oral olarak verilmiştir. Grup VI’ya diklofenak sodyum oral olarak verilmiştir. Deney sürecinde aralıklı olarak grupların ağırlık ölçümleri, sağ pençe çevresi ölçümleri ve klinik artrit skorları takip edilmiştir. Deney sonunda deneklerden alınan kan örneklerinden serum TNF-α, IL-1 β, IL-6 çalışılmıştır. Alınan doku örneklerinden histopatolojik olarak inflamasyon skoru, sinovyal hiperplazi, kıkırdak erozyonu ve kemik erozyonu değerlendirilmiştir. Alınan doku örneklerinden immunohistokimyasal TNF-α değerlendirilmiştir. BULGULAR: Sr kloridin anti-inflamatuvar etkileri değerlendirmelerde gösterilmiştir. Serum örneklerinden çalışılan TNF-α, IL-1 β, IL-6 seviyelerinde gruplar arasında anlamlı farklılık yoktu. İmmunohistokimyasal TNF-α değerlendirmesinde kontrol grubu hariç diğer gruplarda anlamlı farklılık yoktu. SONUÇ: Çalışmamızda Sr kloridin anti-inflamatuvar etkileri klinik ve histopatolojik değerlendirmeler ile gösterilmiştir. Bu sonuçlar Romatoid Artrit tedavisinde Sr kloridin kullanılabileceğini düşündürmektedir.